The GS model also outperformed established clinical prognostic factors, including neoplasm grade, IDH1 mutation status, and MGMT promoter methylation, as indicated by higher area-under-the-curve (AUC) values in ROC curves (Figure 3K). This evidence concerns the gene MGMT and neoplasm.